BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3660765)

  • 21. An experiment with glycerol-frozen red blood cells stored at -80 degrees C for up to 37 years.
    Valeri CR; Ragno G; Pivacek LE; Cassidy GP; Srey R; Hansson-Wicher M; Leavy ME
    Vox Sang; 2000; 79(3):168-74. PubMed ID: 11111236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of storage on oxygen dissociation of canine blood.
    Ou D; Mahaffey E; Smith JE
    J Am Vet Med Assoc; 1975 Jul; 167(1):56-8. PubMed ID: 238923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Freeze-preserved baboon red blood cells: effects of biochemical modification and perfusion in vitro.
    Valeri CR; Lindberg JR; Contreras TJ; Lowrie GB; Pivacek LE; Gray A; Valeri DA; Emerson CP
    Am J Vet Res; 1981 Sep; 42(9):1590-4. PubMed ID: 7325468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydroxyacetone, pyruvate, and phosphate effects on 2,3 DPG and ATP in citrate-phosphate-dextrose-adenine blood preservation.
    Dawson RB; Fagan DS; Meyer DR
    Transfusion; 1984; 24(4):327-9. PubMed ID: 6464157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on citrate-phosphate-dextrose (CPD) blood supplemented with adenine.
    Akerblom O; Kreuger A
    Vox Sang; 1975; 29(2):90-100. PubMed ID: 238338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttransfusion survival of red cells frozen for 8 weeks after 42-day liquid storage in AS-3.
    Rathbun EJ; Nelson EJ; Davey RJ
    Transfusion; 1989; 29(3):213-7. PubMed ID: 2922788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical evaluation of citrate-phosphate-dextrose-adenine blood.
    Kreuger A; Akerblom O; Högman CF
    Vox Sang; 1975; 29(2):81-9. PubMed ID: 807039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of adenosine triphosphate and 2,3-diphosphoglycerate after twenty-four hours in red cells washed for neonatal transfusion.
    Wrotnowski U; Gray LS; Anderson G; Samsell JE; Mintz PD
    Vox Sang; 1988; 54(2):71-3. PubMed ID: 3376466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Red cell storage for 56 days in modified DPD-adenine. An in vitro evaluation.
    Moore GL; Ledford ME; Unruh KA; Brummell MR
    Transfusion; 1981; 21(6):699-701. PubMed ID: 7314217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The survival, function, and hemolysis of human RBCs stored at 4 degrees C in additive solution (AS-1, AS-3, or AS-5) for 42 days and then biochemically modified, frozen, thawed, washed, and stored at 4 degrees C in sodium chloride and glucose solution for 24 hours.
    Valeri CR; Pivacek LE; Cassidy GP; Ragno G
    Transfusion; 2000 Nov; 40(11):1341-5. PubMed ID: 11099662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acid-citrate-dextrose-phosphoenolpyruvate medium as a rejuvenant for blood storage.
    Hamasaki N; Hirota-Chigita C
    Transfusion; 1983; 23(1):1-7. PubMed ID: 6829052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
    Moroff G; Dende D
    Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood preservation. XXIX. Pyruvate maintains normal red cell 2,3-DPG for six weeks of storage in CPD-adenine.
    Dawson RB; Hershey RT; Myers CS
    Transfusion; 1980; 20(2):218-23. PubMed ID: 7368270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood preservation. XXXIV. DHA maintains 2,3-DPG and its adverse effect on ATP is reversed with extra phosphate.
    Dawson RB; Meyer DR; Hedian KA; Hershey RT; Myers CS
    Transfusion; 1980; 20(3):311-5. PubMed ID: 7385325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Storage of ADSOL-preserved red cells at 2.5 and 5.5 degrees C: comparable retention of in vitro properties.
    Moroff G; Holme S; Keegan T; Heaton A
    Vox Sang; 1990; 59(3):136-9. PubMed ID: 2124752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Half-strength citrate CPD and new additive solutions for improved blood preservation. I. Studies of six experimental solutions.
    Högman CF; Eriksson L; Gong J; Payrat JM; Debrauwere J
    Transfus Med; 1993 Mar; 3(1):43-50. PubMed ID: 8038896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of four additive solutions on canine leukoreduced red cell concentrate quality during storage.
    Lacerda LA; Hlavac NR; Terra SR; Back FP; Jane Wardrop K; González FH
    Vet Clin Pathol; 2014 Sep; 43(3):362-70. PubMed ID: 25135622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood preservation. XLIII. Studies on the ascorbate mechanisms of maintaining red cell 2,3-DPG.
    Dawson RB; Dabezies M; Hershey RT; Myers CS; Miller RM
    Transfusion; 1980; 20(3):316-20. PubMed ID: 7385326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of blood oxygen affinity in different CPD solutions during liquid storage.
    Wells RM; Hill RS; Woodfield DG
    Transfusion; 1981; 21(6):709-14. PubMed ID: 7314220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood preservation. XXVIII. Galactose and maltose maintain red blood cell 2,3-DPG and ATP.
    Dawson RB; Hershey RT; Myers CS; Zuck TF
    Transfusion; 1980; 20(1):110-3. PubMed ID: 7355460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.